3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Biopsy
17
Specimen Handling
16
Magnetic Resonance Spectroscopy
15
Cyclophosphamide
14
Rituximab
12
obinutuzumab
8
Lenalidomide
8
fludarabine
7
Prednisone
7
pembrolizumab
6
Nuclear Medicine Department, Hospital
6
Doxorubicin
5
glofitamab
4
fludarabine phosphate
4
X-Rays
4
Vincristine
4
Tacrolimus
4
Mycophenolic Acid
4
Etoposide
4
Busulfan
4
venetoclax
3
trametinib
3
sapanisertib
3
ibrutinib
3
copanlisib
3
acalabrutinib
3
Whole-Body Irradiation
3
Nivolumab
3
GSK2636771
3
Crizotinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
tislelizumab
×
30 days
×
Clear all
No trials found.